课题基金 / 基金详情

Functional analysis of p53-target genes.

Functional analysis of p53-target genes.
p53 靶基因的功能分析。
批准号:
11138246
负责人:
TOKINO Takashi
金额:
$8.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 --

项目摘要

项目成果

TOKINO Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We isolated p53-binding sites by genetic approach in yeast and then identified novel p53-target genes. One of these, called BAl1 , which was expressed in brain and repressed in 8/9 glioblastomas, was further characterized to inhibit neovascularization in the rat cornea by basic FGF.To investigate the in vivo anti-angiogenic effect of BAl1 gene on a human glioblastoma cell line, p53-defective human glioblastoma cells U373MG were transduced with the BAl1 gene using a recombinant adenoviral vector. In vivo neovascularization assay of the BAl1-infected glioblastoma cells was then performed using skinfold chamber system transplanted in SCID mice and revealed that BAl1 transduction resulted in reduced neovascurization in SCID mice.Expression of the glycosyl-phosphatidylinositol-anchored molecule-like protein (GML) gene, another p53 target, correlates with the sensitivity of some cancer cell lines to anticancer drugs and ionizing radiation. To investigate the function of GML further, we introduced the GML cDNA into various cancer cell lines under control of the tetracycline-regulated system. When we introduced GML into human glioblastoma cell line T98G, which lacks wild-type p53 and expresses no endogenous GML, we observed significant growth suppression accompanied by G2/M arrest in two independent, stable cell lines. We confirmed introduction of apoptosis by fluorescence-activated cell sorting (FACS) analysis and nuclear staining. Our results indicated that GML could induce apoptosis of T98G without functional p53, and implied that GML plays a crucial role in the apoptosis pathway in some cancer cells.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
時野隆至: "臨床家のためのがん遺伝子/がん制御遺伝子"南江堂. 198 (1999)
Takashi Tokino:“临床医生的癌基因/癌症调节基因”Nankodo 198 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishida,S. et al: "Adenovirus-nediated transfer of p53-related genes induces apoptosis of human cancer cells."Jpn.J.Cancer Res.. 91(発表予定). (2000)
Ishida,S.等人:“腺病毒介导的p53相关基因的转移诱导人类癌细胞的凋亡。”Jpn.J.Cancer Res..91(待出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oda K, Shiratsuchi T, Nishimori H, Inazawa J, Yoshilkawa H, Takatani Y, Nakamura V, Tokino T: "Identification of BAIAP2 (BAI-associated protein 2), a novel human homologue of hamster IRSp53, whose SH3 domain interacts with the cytoplasmic domain of Bal1."
Oda K、Shiratsuchi T、Nishimori H、Inazawa J、Yoshilkawa H、Takatani Y、Nakamura V、Tokino T:“BAIAP2(BAI 相关蛋白 2)的鉴定,它是仓鼠 IRSp53 的一种新型人类同源物,其 SH3 结构域与
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    A better understanding of p53 network for cancer therapy
    • 批准号:
      16K07122
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2016
    • 负责人:
      TOKINO Takashi
    • 依托单位:
    New insights into p53 signaling regulation to cure cancer
    • 批准号:
      25430115
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2013
    • 负责人:
      TOKINO Takashi
    • 依托单位:
    High-throughput screening for peptides that inhibit the interaction or MDM4 with p53
    • 批准号:
      23659658
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      TOKINO Takashi
    • 依托单位:
    Functional analysis of CHFR: Diagnostic and therapeutic application for oral squamous cell cancer
    • 批准号:
      20390519
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2008
    • 负责人:
      TOKINO Takashi
    • 依托单位:
    国内基金
    海外基金
    基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
    • 批准号:
      2026JJ82384
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      颜志鹏
    • 依托单位:
    Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
    APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
    • 批准号:
      JCZRQNB202600696
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究